Market Place
Sourcing Support
FDA Confirms Para IV Patent Litigation for Suvorexant (Calquence) Tablets
26 Apr 2024 //
FDA
Suvorexant Increases Sleep Time in Patients With Alzheimer Dementia, Insomnia
03 Sep 2020 //
NEUROLOGYLIVE
Merck gets Alzheimer’s label claim for insomnia drug Belsomra
05 Feb 2020 //
PMLIVE
Experts doubtful of Idorsia’s daridorexant uptake potential in insomnia
27 Jan 2020 //
CLINICALTRIALSARENA
World first clinical trial commences in alcohol use disorder
28 Oct 2019 //
BIOSPECTRUMASIA
Trial to test insomnia drug for alcohol use disorder
25 Oct 2019 //
CLINICALTRIALSARENA
Merck’s BELSOMRA® C-IV Meets Primary Efficacy Endpoint in Pha3 Trial
07 May 2019 //
BUSINESSWIRE
Pharma`s DTC ad spending soars past $5B in 2015
07 Mar 2016 //
FIERCE PHARMA MARKETING
Jardiance, Belsomra and Entyvio brand managers share DTC honors with oldsters
29 Feb 2016 //
FIERCE PHARMA MARKETING
AbbVie`s Humira repeats, joined by BMS` Opdivo in leading TV spending
18 Nov 2015 //
FIERCE PHARMA MARKETING
Real-life insomnia stories at core of new Merck-backed awareness campaign
09 Nov 2015 //
FIERCE PHARMA MARKETING
Merck`s Quest To Revive The Market For Insomnia Drugs
05 Jun 2015 //
FORBES
Merck Execs Tout Early Yield From Sleep Drug Belsomra`s Launch
12 Mar 2015 //
FIERCE PHARMAMARKETING
US Roll out for Merck`s First-in-Class Sleep Drug
03 Feb 2015 //
PHARMA TIMES
Merck`s Insomnia Medicine BELSOMRA
03 Feb 2015 //
MERCK
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.